Resmetirom for MASH patients with diabetes: challenges and opportunities in the real world

Metabolism. 2024 Jul:156:155935. doi: 10.1016/j.metabol.2024.155935. Epub 2024 May 15.
No abstract available

Publication types

  • Editorial
  • Letter

MeSH terms

  • Diabetes Mellitus* / therapy
  • Diabetes Mellitus, Type 2
  • Humans
  • Hypoglycemic Agents / therapeutic use

Substances

  • Hypoglycemic Agents